Zimbabwe has rejected a substantial US health deal worth $367m (272 million pounds) spanning five years because of Washington's demand for sensitive information.
This rejection was revealed after a official document dated December was disclosed, indicating that President Emmerson Mnangagwa believed the agreement was "lopsided".
An official representative later clarified that the US was seeking health data for research and profit while was unwilling to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged more dialogue to secure a deal agreeable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Implications
This development follows a similar situation in neighbouring Kenya, where a court suspended a related deal with the US after legal challenges were raised about the safety of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking direct bilateral deals to enhance transparency and accountability.
Based on reports, Sixteen African countries have so far signed similar agreements, representing over $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy through American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Effectively, our nation would provide the raw materials for medical research without any certainty that the final treatments would be available to our population should a new disease outbreak emerge."
National Interest and International Frameworks
He also noted that the American exit from the global health body and its pursuit of bilateral deals were upending frameworks already set up through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.
"This system is designed to guarantee that when a country contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how subsequent collaboration might be structured in a manner that respects the independence and dignity of each country."
Medical Community Reaction
Medical experts expressed it recognised the official position, but suggested that negotiations need to persist given that much of the country's HIV programmes relied on international support.
"Where specific concerns arise, including those relating to information security or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," the group commented.
This impasse underscores the complex tensions between accepting crucial international aid and safeguarding local interests in an ever more interconnected world.